These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4340721)

  • 41. [The aetiology of rheumatoid arthritis (author's transl)].
    Denman AM
    Immun Infekt; 1976 Apr; 4(2):37-51. PubMed ID: 1085744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei.
    Tojo T; Friou GJ
    Science; 1968 Aug; 161(3844):904-6. PubMed ID: 4174454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunofluorescent patterns and specificity of human antinuclear antibodies.
    Bickel YB; Barnett EV; Pearson CM
    Clin Exp Immunol; 1968 Sep; 3(7):641-56. PubMed ID: 4973611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 45. [Rheumatoid factor in systemic lupus erythematosus].
    Strejcek J; Dostál C
    Allerg Immunol (Leipz); 1976; 22(4):357-61. PubMed ID: 141867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis.
    Shirodaria PV; Haire M; Fleming E; Merrett JD; Hawkins SA; Roberts SD
    Arch Neurol; 1987 Dec; 44(12):1237-41. PubMed ID: 2823754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement-fixing activity of rheumatoid synovial fluid.
    Townes AS; Marcus RL
    Ann Rheum Dis; 1972 Sep; 31(5):393-401. PubMed ID: 5071634
    [No Abstract]   [Full Text] [Related]  

  • 48. The heterogeneity of serologic findings and predisposing host factors in drug-induced lupus erythematosus.
    Hughes GR; Rynes RI; Gharavi A; Ryan PF; Sewell J; Mansilla R
    Arthritis Rheum; 1981 Aug; 24(8):1070-3. PubMed ID: 6974553
    [No Abstract]   [Full Text] [Related]  

  • 49. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Petersen J; Rhodes G; Roudier J; Vaughan JH
    Arthritis Rheum; 1990 Jul; 33(7):993-1000. PubMed ID: 2164400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases.
    Schur PH; Stollar BD; Steinberg AD; Talal N
    Arthritis Rheum; 1971; 14(3):342-7. PubMed ID: 4998028
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative study and importance of 3 technics for research of anti-DNA antibdoies. (Immunofluorescence on the Trypanosoma gambieuse nucleus, complement fixation, test conditioned hemagglutination)].
    Monier JC; Thivolet J; Sepetjian M
    Ann Inst Pasteur (Paris); 1968 Sep; 115(3):403-15. PubMed ID: 4886013
    [No Abstract]   [Full Text] [Related]  

  • 52. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 53. Virus antibodies and multiple sclerosis.
    Sever JL; Kurtzke JF; Alter M; Schumacher GA; Gilkeson MR; Ellenberg JH; Brody JA
    Arch Neurol; 1971 Jun; 24(6):489-94. PubMed ID: 4326199
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of DNA-binding activity of blood serum in systemic lupus erythematosus, rheumatoid arthritis and crossing syndromes].
    Matveĭkov GP; Podgorodnichenko VK; Koshelev VK; Nazarov IuM
    Ter Arkh; 1976; 48(11):36-40. PubMed ID: 1021891
    [No Abstract]   [Full Text] [Related]  

  • 55. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
    Sculley TB; Pope JH; Hazelton RA
    Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The multifactorial etiology of rheumatic diseases.
    Barnett EV
    J Rheumatol; 1975 Jun; 2(2):125-9. PubMed ID: 1097681
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum antibodies to fetal antigens in systemic lupus erythematosus and rheumatoid arthritis.
    Salinas FA; Quismorio FP; Friou GJ
    Clin Immunol Immunopathol; 1978 Dec; 11(4):388-94. PubMed ID: 310372
    [No Abstract]   [Full Text] [Related]  

  • 58. Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases.
    Halla JT; Schrohenloher RE; Volanakis JE
    Ann Intern Med; 1980 Jun; 92(6):748-52. PubMed ID: 7387017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Inhibiting action of chloroquine and para-aminobenzoic acid on the agglutinating activity of the rheumatoid factor].
    CHIEREGATO G; TOSO M
    Minerva Dermatol; 1961 Dec; 36():454-7. PubMed ID: 13878939
    [No Abstract]   [Full Text] [Related]  

  • 60. Rheumatoid factor and antinuclear antibody in systemic lupus erythematosus, rheumatoid arthritis and infectious mononucleosis.
    Ichida CK; Yokoyama M
    Hawaii Med J; 1971; 30(3):170-3. PubMed ID: 4105320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.